Cancer prevalence set to treble

August 21, 2012 in Cancer

Cancer prevalence set to treble

(Medical Xpress) -- The number of older people (aged 65 and over) living with cancer in the UK is set to more than treble by 2040 – from 1.3 million in 2010 to 4.1 million – according to a new study by King’s College London researchers.

The Macmillan-funded study, published in The British Journal of , shows nearly one in four (23 per cent) will have had a cancer diagnosis in 2040 – almost double the proportion in 2010 (13 per cent). This is nearly four times the proportion for people aged 45-64.

Lung cancer prevalence in older women will see the biggest increase. The prevalence of lung cancer in older women will more than double from in 2010 to 2040 (from 319 to 831 per 100, 000), whereas lung cancer prevalence in older men is expected to decrease. This is due to a dramatic decline in smoking among men in England since the 1970s.

The sharp rise in cancer prevalence is likely to be due to a number of reasons including the ageing population, increasing incidence and increasing cancer survival.

Professor Henrik Møller, one of the study authors at King’s, says: ‘The aim of this research is to provide long term projections of cancer prevalence in the UK. The research shows that large increases can be expected in the oldest age groups in the coming decades and with this an increased demand upon health services.’

Currently older face a multitude of barriers to getting the best care and . These include under treatment, a lack of practical support at home preventing them from going to hospital to get treatment and poor management of non-cancer related health problems.

Ciarán Devane, Chief Executive at Macmillan Cancer Support, said: ‘The care of older cancer patients is the ticking time bomb for society. These stark predictions should act as a warning to the NHS and social care providers of the problems ahead if older cancer patients are not offered the best treatment and support.

‘We have a moral duty to give people the best chance of beating cancer, regardless of their age. For cancer survival to improve, older people must be given the right treatment at the correct level of intensity, together with the practical support to enable them to take it up.

‘The barriers to older people getting treatment must be tackled. If we don’t get this right now many older people will be dying unnecessarily from cancer in the future.’

Macmillan is calling for a more effective way of assessing older people for treatment, more short-term practical support to enable them to take up recommended treatment and training for professionals working with older people within the NHS to promote age equality.

Macmillan, in partnership with Age UK and the Department of Health, has set up five pilots to test new models of older people’s care. They will report in December 2012.

More information: Maddams J, Utley M and Møller H. 2012. 'Projections of cancer prevalence in the United Kingdom, 2010–2040'. British Journal of Cancer. www.nature.com/bjc… 012366a.html

Journal reference: British Journal of Cancer search and more info website

Provided by King's College London search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

New smartphone application improves colonoscopy preparation

The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...

Cancer created 11 hours ago | popularity not rated yet | comments 0

Research examines new methods for managing digestive health

Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.

Cancer created 11 hours ago | popularity not rated yet | comments 1

New colonoscope provides ground-breaking view of colon

A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...

Cancer created May 18, 2013 | popularity 5 / 5 (2) | comments 0

ASCO: combo antibody therapy effective for melanoma

(HealthDay)—Concurrent use of two immune checkpoint antibodies—ipilimumab and nivolumab—may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in ...

Cancer created May 17, 2013 | popularity not rated yet | comments 0

Risk factors ID'd for poor cutaneous cell CA outcomes

(HealthDay)—The risks of metastasis and death associated with cutaneous squamous cell carcinoma (CSCC) are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond ...

Cancer created May 17, 2013 | popularity not rated yet | comments 0 | with audio podcast


Computational tool translates complex data into simplified 2-dimensional images

In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...

New theory on genesis of osteoarthritis comes with successful therapy in mice

Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...

Alzheimer's leaves bilingual victims stranded in Canada

The devastating effect of Alzheimer's disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.

Consuming coffee linked to lower risk of detrimental liver disease, study finds

Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...

Ketamine shows significant therapeutic benefit in people with treatment-resistant depression

Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...